Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanxi Zhang

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Cancer Discovery|June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung CancerHaikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Nature Medicine|July 25, 2018
Tumor innate immunity primed by specific interferon-stimulated endogenous retrovirusesIsrael Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Cancer Discovery|June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung CancerHaikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Nature Medicine|July 25, 2018
Tumor innate immunity primed by specific interferon-stimulated endogenous retrovirusesIsrael Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Pageof 6